How Your In-Network Health Coverage Can Vanish Before You Know It
One of the most unfair aspects of medical insurance is this: Patients can change insurance only during end-of-year enrollment periods or at the time of “qualifying life events.” But insurers’ contracts with doctors, hospitals, and pharmaceutical companies can change abruptly at any time.
GoFundMe Has Become a Health Care Utility
Resorting to crowdfunding to pay medical bills has become so routine, in some cases health professionals recommend it.
GoFundMe, ¿realmente ayuda a pagar facturas médicas?
Incluso defensores de pacientes y personal del área de ayuda financiera en hospitales recomiendan iniciar una sesión en GoFundMe como una alternativa a terminar con una cuenta en una agencia de cobros.
The FTC Is Attacking Drugmakers’ ‘Patent Thickets’
It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.
Ouch. That ‘Free’ Annual Checkup Might Cost You. Here’s Why.
The designers of the Affordable Care Act might have assumed that they spelled out with sufficient clarity that millions of Americans would no longer have to pay for certain types of preventive care. But they didn’t reckon with America’s ever-creative medical billing juggernaut.
From Hospital to Hospitality: Spin Doctors Brand Getting Sick as an Adventure. It’s Not.
At $1,000 a night for a private room, medical centers are offering fancy food and casting health care as a “journey.” Instead of creature comforts, how about helping us feel better?
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
The Shrinking Number of Primary Care Physicians Is Reaching a Tipping Point
The declining share of U.S. doctors in adult primary care is about 25% — a point beyond which many Americans won’t be able to find a family doctor at all.
A Peek at Big Pharma’s Playbook That Leaves Many Americans Unable to Afford Their Drugs
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?
Sin barreras, los precios de algunos medicamentos existentes se han disparado, incluso cuando han caído drásticamente en otros países. Los nuevos medicamentos tienen precios enormes, respaldados por el lobby y el marketing.